Pacific Biosciences of California, Inc. - PACB

SEC FilingsOur PACB Tweets

About Gravity Analytica

Recent News

  • 06.04.2026 - The microbial world is everywhere. Long-read sequencing is finally allowing us to see it clearly.
  • 05.28.2026 - The pivotal decisions that make for great sequencing data
  • 05.26.2026 - PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing
  • 05.21.2026 - PacBio to Participate in the Jefferies Global Healthcare Conference
  • 05.21.2026 - Publication spotlight: How one HiFi sequencing assay can bring clarity to unexplained infertility
  • 05.14.2026 - The power of one: How assay consolidation and menu expansion reshape sequencing economics
  • 05.11.2026 - HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss
  • 05.08.2026 - Long-read sequencing is not the trade-off it used to be: These are the 5 questions that show why
  • 05.07.2026 - PacBio Announces First Quarter 2026 Financial Results
  • 04.30.2026 - Improving HiFi sequencing accuracy with Google DeepConsensus and AlphaEvolve

Recent Filings

  • 05.27.2026 - SD Specialized disclosure report
  • 05.22.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
  • 05.08.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 05.07.2026 - EX-99.1 EX-99.1
  • 05.07.2026 - 8-K Current report
  • 04.23.2026 - ARS Annual Report to Security Holders
  • 04.23.2026 - DEF 14A Other definitive proxy statements
  • 04.23.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material